SPCE:NYSEVirgin Galactic Holdings, Inc. Analysis
Data as of 2026-05-26 - not real-time
$3.24
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Virgin Galactic trades at $3.24, comfortably above its 20‑day (2.66) and 50‑day (2.67) SMAs but still below the 200‑day SMA (3.15), indicating a short‑term bounce within a longer‑term bearish framework. The RSI sits at 63, suggesting momentum remains healthy but not overbought, while a bullish MACD histogram (+0.028) adds technical support for upside. Volume is on an increasing trend, and the stock holds a clear support zone around $2.27 and resistance near $3.42, framing the current price range. However, the equity exhibits extreme volatility (103% 30‑day) and a high beta of 2.0, making price swings pronounced. Fundamentals are weak: the company is pre‑revenue, with negative operating cash flow, a debt‑to‑equity of 143%, and a net‑debt position of roughly $100 M, while the price‑to‑book (0.87) is below book value, hinting at a modest valuation cushion.
The most material catalyst is the announced schedule to begin Delta‑class flight testing in Q3 2026 and a rocket‑powered flight in Q4 2026, which could unlock commercial revenue streams and improve analyst sentiment. Consensus estimates show a modest upside of ~9.5% (median target $3.20, mean $3.55) amid an “Extreme Greed” market mood. Investors should weigh the upside from upcoming milestones against the high operational risk, debt load, and price volatility when forming a position.
The most material catalyst is the announced schedule to begin Delta‑class flight testing in Q3 2026 and a rocket‑powered flight in Q4 2026, which could unlock commercial revenue streams and improve analyst sentiment. Consensus estimates show a modest upside of ~9.5% (median target $3.20, mean $3.55) amid an “Extreme Greed” market mood. Investors should weigh the upside from upcoming milestones against the high operational risk, debt load, and price volatility when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume support a near‑term bounce
- Price remains below 200‑day SMA, indicating broader bearish bias
- High volatility and beta increase downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Scheduled Delta‑class test and Q4 rocket flight could trigger revenue
- Analyst price targets imply modest upside
- Improving technical momentum despite weak fundamentals
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term growth potential in commercial space tourism
- Significant debt load and ongoing cash burn
- Regulatory and safety approvals remain uncertain
Key Metrics & Analysis
Financial Health
Revenue Growth-50.80%
P/E Ratio-6.7
ROE-104.51%
ROA-19.84%
Debt/Equity142.91
P/B Ratio0.9
Op. Cash Flow$-217724992
Free Cash Flow$-303645632
Industry P/E29.7
Technical Analysis
TrendBearish
RSI63.3
Support$2.27
Resistance$3.42
MA 20$2.66
MA 50$2.67
MA 200$3.15
MACDBullish
VolumeIncreasing
Fear & Greed Index91.77
Valuation
Target Price$3.55
Upside/Downside9.57%
GradeFair
TypeGrowth
Risk Assessment
Beta2.01
Volatility103.20%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.